Today I’m working on a market research study that we are conducting in partnership with a medcomms company. The survey is intended to extract the perceptions and attitudes of healthcare professionals on the topic of openness and transparency of clinical trial reporting. How aware are physicians of the controversy surrounding pharma sponsorship and ghostwriters and to what extent do they actually care or perceive it as a problem?
We’ll be asking registered users of our professional portal (www.epgonline.org) to participate and will report the results in January. Whatever the results show, they should be very interesting, especially since no such studies currently exist (I believe). I’ll be sure to make the report freely available to the Medcomms Networking Community (if that’s ok with Peter), so watch this space!
Have a good medcomms day.